Sex-based short- and long-term survival in patients following complicated myocardial infarction
Vernon V S Bonarjee1, Annika Rosengren, Steven M Snapinn
1University of Bergen, Stavanger University Hospital, Stavanger, Norway. bove@sir.no
European Heart Journal
|August 3, 2006
Summary
Women with acute myocardial infarction (AMI) face higher in-hospital mortality, despite similar long-term survival after age adjustment. This highlights the need for prompt, tailored management for female AMI patients.
Area of Science:
- Cardiology
- Clinical Research
- Sex Differences in Medicine
Background:
- Mortality after acute myocardial infarction (AMI) is higher in women than men.
- Women are typically older and have more comorbidities at the time of AMI.
Purpose of the Study:
- To investigate sex-based differences in the management and prognosis of high-risk patients post-AMI.
- To evaluate short- and long-term outcomes in women versus men following AMI.
Main Methods:
- Analysis of data from the OPTIMAAL trial, including 1575 women and 3902 men with AMI.
- Follow-up period of 2.7+/-0.9 years across seven European countries.
- Comparison of management strategies and mortality rates, adjusting for age and comorbidities.
Main Results:
- Women presented with more symptomatic heart failure, hypertension, and diabetes mellitus.
- Fewer women received thrombolytic therapy compared to men.
- While long-term mortality risk was similar after age adjustment, in-hospital mortality was significantly higher in women, persisting even after adjusting for age and comorbidities.
Conclusions:
- Age-adjusted long-term survival post-AMI is comparable between sexes in high-risk populations.
- Women experience significantly higher in-hospital mortality following AMI.
- These findings suggest a need for more rapid and appropriate management strategies for women presenting with AMI to address short-term risks.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
200
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
200
Myocarditis I: Introduction
343
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
343
Acute Coronary Syndrome III: Diagnostic Studies
199
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
Acute Coronary Syndrome I: Introduction
736
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
736
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
763
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
763
Assumptions of Survival Analysis
385
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
385


